A Randomized, Double-blind, Active-and Placebo-controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naive to Biologic Disease Modifying Antirheumatic Drugs with Active Psoriatic Arthritis

被引：0

作者：

Mease, Philip ^{[1
,2
]}

van der Heijde, Desiree ^{[3
]}

Ritchlin, Christopher ^{[4
]}

Cuchacovich, Raquel ^{[5
]}

Shuler, Catherine ^{[6
]}

Lin, Chen-Yen ^{[6
]}

Vangerow, Harald ^{[6
]}

Samanta, Suvajit ^{[6
]}

Lee, Chin ^{[6
]}

Gladman, Dafna ^{[7
]}

机构：

[1] Swedish Med Ctr, Dept Rheumatol, Seattle, WA USA

[2] Univ Washington, Seattle, WA 98195 USA

[3] Leiden Univ, Leiden, Netherlands

[4] Univ Rochester, Med Ctr, Allergy Immunol & Rheumatol Div, Rochester, NY 14642 USA

[5] Indiana Univ Sch Med, Div Rheumatol, Dept Med, Indianapolis, IN 46202 USA

[6] Eli Lilly & Co, Indianapolis, IN 46285 USA

[7] Univ Toronto, Toronto, ON, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1169 / 1169

页数：1